Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus

Indian J Pediatr. 2005 Aug;72(8):671-4. doi: 10.1007/BF02724075.

Abstract

Aim: To describe the presentation and outcome of rhino-orbital-cerebral mucormycosis (ROCM) in adolescents with type 1 diabetes mellitus (T1DM).

Methods: The medical records of six patients of T1DM with ROCM admitted between October 2001 to January 2004 were analysed.

Results: The mean (+/- SD) age and duration of DM of these patients were 16.1+/-3.0 years and 26.3 +/- 24.9 months respectively. Four patients had ROCM at presentation, while two developed it during their hospital stay when recovering from diabetic ketoacidosis. Proptosis (100%) and ptosis (100%) were the most common symptoms, and ophthalmoplegia (85%) and vision loss (85%) were the most common signs. Maxillary sinus (85%) was the commonest paranasal sinus to be involved. All patients received amphotericin B and had appropriate surgery except one. Four patients survived. Patients who had altered sensorium, facial necrosis, palatal perforation and cerebral involvement at presentation had poor outcome.

Conclusion: High index of suspicion of ROCM in T1DM and combined approach with amphotericin B and appropriate surgery is rewarding.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Cerebral Infarction / etiology
  • Cerebral Infarction / mortality
  • Child
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 1 / mortality
  • Fatal Outcome
  • Humans
  • Mucormycosis / diagnosis
  • Mucormycosis / etiology*
  • Mucormycosis / therapy
  • Nose Diseases / etiology*
  • Nose Diseases / therapy
  • Patient Compliance
  • Prognosis
  • Retrospective Studies

Substances

  • Antifungal Agents
  • Amphotericin B